Beyond Cas9

While CRISPR/Cas9 may be the most famous of the CRISPR gene editing approaches, other enzymes may have their niches, the Wall Street Journal says.

North Carolina State University's Rodolphe Barrangou, for instance, is using Cas3 in his work on antibiotic resistance. "Cas3 is a meaner system and more cumbersome than Cas9," he tells the Journal. "But if you want to cut a tree and get rid of it, you bring a chain saw, not a scalpel."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.